NCT01657448 - Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria | Biotech Hunter

Enrollment

316

Participants

Timeline

Start Date

June 27, 2016

Primary Completion Date

November 21, 2016

Study Completion Date

December 22, 2017

Conditions

Dysuria

Interventions

DRUG

Methenamine and Methylthioninium chloride

• Ingesting two (02) tablets of the drug with a glass of water, every 8 hours for 3 days

DRUG

Phenazopyridine

• Ingesting two (02) tablets of the drug with a glass of water, every 8 hours for 3 days

Trial Locations (4)

Centro de Medicina Reprodutiva Carlos Isaia Filho Ltda, Porto Alegre

Marcio Antonio Pereira Clinica de Endocrinologia, São José dos Campos

AFIP, São Paulo

Savmed Clinica Médica S/C Ltda., São Paulo